Biomarkers in diabetic neuropathy

Context The prevalence of diabetic neuropathy is drastically increasing in the world. To halt the progression of diabetic neuropathy, there is an unmet need to have potential biomarkers for the diagnosis and new drug discovery. Objective To study various biomarkers involved in the pathogenesis of diabetic neuropathy. Methods The literature was searched with the help of various scientific databases and resources like PubMed, ProQuest, Scopus, and Google scholar from the year 1976 to 2020. Results Biomarkers of diabetic neuropathy are categorised as inflammatory biomarkers such as MCP-1, VEGF, TRPV1, NF-kappa B; oxidative biomarkers such as adiponectin, NFE2L2; enzyme biomarkers like NADPH, ceruloplasmin, HO-1, DPP-4, PARP alpha; miscellaneous biomarkers such as SIRT1, caveolin 1, MALAT1, and microRNA. All biomarkers have a significant role in the pathogenesis of diabetic neuropathy. Conclusion These biomarkers have a potential role in the progression of diabetic neuropathy and can be considered as potential targets for new drug discovery.

Automated summary

The prevalence of diabetic neuropathy is increasing, and there is a need to find potential biomarkers for diagnosis and new drug discovery. This study identified various biomarkers involved in the pathogenesis of diabetic neuropathy through a literature search. These biomarkers play a significant role in the progression of diabetic neuropathy.